Mirikizumab-mrkz Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Dec 22, 2025 · last update Dec 22, 2025
Manufacturers: Eli Lilly and Co.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Omvoh, Injection, 100 mg/1 mL (NDC 0002-8011-27) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-3116-11) will remain. | Posted Dec 22, 2025 Updated Dec 22, 2025 Discontinued Dec 22, 2025 |
| Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-1442-11) will remain. | Posted Dec 22, 2025 Updated Dec 22, 2025 Discontinued Dec 22, 2025 |